As clinical development becomes increasingly complex and costly, biotech and pharmaceutical companies are rethinking how they partner with contract research organizations (CROs) to harmonize speed, ...
Company remains on track for anticipated IND filing in Q3 2026, marking a transformative step toward becoming a ...
Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and autoimmune disease ...
Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today presented 3-year landmark overall survival data from ...
The 2025-2027 approval helps French innovators access Intravacc’s vaccine development, analytical development and cGMP manufacturing services ...
Pre-IND meeting has been scheduled with FDA to advance type 1 diabetes treatment to First-In-Human clinical trial ZURICH, Switzerland, May 27, 2026 (GLOBE NEWSWIRE) -- NewcelX Ltd. ("NewcelX"; Nasdaq: ...
Product Revenue -- $0.4 million, decreased from $0.8 million, reflecting limited commercial activity and ongoing investment ...
TAIPEI and SHANGHAI and SAN FRANCISCO, May 26, 2026 /PRNewswire/ -- HanchorBio, Inc. (TPEx: 7827), a global clinical-stage ...
Epigenetic aging clocks use DNA methylation patterns to measure biological age and predict health risks across human tissues.
We are delighted to receive this Horizon Europe grant, which is a further validation of both our scientific approach ...
The article discusses medical robotics, embedded systems, and healthcare technologies used in modern clinical environments, ...
These projects are not only about adding beds or buildings; they represent a broader effort to bring advanced care, clinical research and new treatments closer to home.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results